Cellectis Est. EPS Q/Q
What is the Est. EPS Q/Q of Cellectis?
The Est. EPS Q/Q of Cellectis is -45.12%
What is the definition of Est. EPS Q/Q?
Prospective quarterly EPS growth rate, year over year, is the estimated increase of the company’s EPS for the current quarter compared to performance from a past corresponding quarter.
= current quarter yoy (year over year)
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Est. EPS Q/Q of companies in the Health Care sector on NASDAQ compared to Cellectis
What does Cellectis do?
cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited t-cells (ucart). by capitalizing on its 18 years of expertise in gene editing – built on its flagship talen® technology and pioneering electroporation system pulseagile – cellectis uses the power of the immune system to target and eradicate cancer cells. using its life-science-focused, pioneering genome engineering technologies, cellectis’ goal is to create innovative products in multiple fields and with various target markets. cellectis is listed on the nasdaq market (ticker: clls) and on the nyse alternext market (ticker: alcls). to find out more about us, visit our website: www.cellectis.com talking about gene editing? we do it. talen® is a registered trademark owned by the cellectis group.
Companies with est. eps q/q similar to Cellectis
- Banco Macro S.A has Est. EPS Q/Q of -45.38%
- American International Inc has Est. EPS Q/Q of -45.36%
- Western Union has Est. EPS Q/Q of -45.31%
- Passage Bio Inc has Est. EPS Q/Q of -45.26%
- Teradyne has Est. EPS Q/Q of -45.26%
- Avanti Feeds has Est. EPS Q/Q of -45.24%
- Cellectis has Est. EPS Q/Q of -45.12%
- Companhia Siderurgica Nacional has Est. EPS Q/Q of -45.00%
- Copperleaf Technologies has Est. EPS Q/Q of -45.00%
- Unity Biotechnology Inc has Est. EPS Q/Q of -45.00%
- Nano Dimension Ltd has Est. EPS Q/Q of -45.00%
- PLx Pharma has Est. EPS Q/Q of -45.00%
- BXP has Est. EPS Q/Q of -44.92%